Skip to content

Clinical trials

Hematologic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20091
20111
20121
20131
20141
20172
20181
20201
20213
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated4
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Novartis Pharmaceuticals3
AstraZeneca2
Amgen1
Celgene Corporation1
Daiichi Sankyo1
Gilead Sciences1
Janssen Pharmaceutical K.K.1
Janssen Research & Development, LLC1
Keio University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms19
Leukemia, Myeloid, Acute6
Bone Marrow Diseases3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Multiple Myeloma3
Myelodysplastic Syndromes3
Neoplasms3
Leukemia2
Leukemia, Myeloid2
Lymphoma, B-Cell2

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.